Download full-text PDF

Source

Publication Analysis

Top Keywords

healthcare financial
4
financial suite
4
suite panel
4
panel discussion
4
healthcare
1
suite
1
panel
1
discussion
1

Similar Publications

Background & objectives Cancer is one of the leading causes of death among older adults worldwide. The global burden of cancer among older individuals is increasing due to the ageing population. The increasing burden of cancer among older adults will pose significant social and economic challenges for the delivery of healthcare services.

View Article and Find Full Text PDF

Background: Improving system coordination is a pivotal strategy and a critical pathway for social governance. Chinese society is currently facing a significant challenge in aligning the allocation of health resources with economic development. Evaluating the level of coordinated development within the system can provide valuable insights to support the construction of a more coordinated China and foster high-quality development.

View Article and Find Full Text PDF

This study aims to enhance the classification accuracy of adverse events associated with the da Vinci surgical robot through advanced natural language processing techniques, thereby ensuring medical device safety and protecting patient health. Addressing the issues of incomplete and inconsistent adverse event records, we employed a deep learning model that combines BERT and BiLSTM to predict whether adverse event reports resulted in patient harm. We developed the Bert-BiLSTM-Att_dropout model specifically for text classification tasks with small datasets, optimizing the model's generalization ability and key information capture through the integration of dropout and attention mechanisms.

View Article and Find Full Text PDF

Unlabelled: Cladribine indirectly downregulates methylation of DNA, RNA, and histones by blocking the transfer of methyl groups from -adenosyl-methionine. The cladribine and rituximab combination showed a synergetic effect in treating B-cell lymphomas. Bortezomib (Velcade) is a Food and Drug Administration (FDA)-approved proteasome inhibitor for treating mantle cell lymphoma (MCL).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!